Nav: Home

New non-surgical treatment for common, vexing eye condition

March 31, 2014

Baltimore, MD, 31 March 2014. - A new report reveals a potential breakthrough in the treatment of a common eye ailment known as pterygium (Surfer's eye) that impacts the vision, eye health, and cosmetic appearance of countless sufferers.

The newly published report shows that eye drops containing the anti-anginal drug dipyridamole (Persantin®, Cardoxin®) led to almost total disappearance of an inflamed pterygium in a 35 year old otherwise healthy woman.

Dipyridamole is a drug in use over the past 55 years to treat other disorders, but now found to have this remarkable new use.

Pterygium is a disorder in which a non-cancerous growth develops on the white conjunctiva of the eye and over time invades the cornea. In some countries it affects up to 25% of the population. As the growth spreads, patients can develop vision problems as well as significant discomfort from complications such as dry eye, inflammation, irritation, and foreign body sensation. Additionally, because of their location in the eyes, pterygia are a cause of substantial cosmetic concern for sufferers.

Until now, eye surgery has been the only curative option, aided by medications trying to lessen the disorder's symptoms. However, even after eye surgery, pterygia often recur.

The new report's lead author, Moshe Rogosnitzky, who is Co-Founder and Director of Research at the MedInsight Research Institute, discovered that administration of dipyridamole eye drops significantly reduced a pterygium and completely resolved the associated inflammation and other symptoms.

Clinical trials are now being plannedfor pterygia, pingueculae, and other common eye disorders and their complications such as dry eye and inflammation.

One particular advantage to this discovery is that dipyridamole is a widely-approved anti-thrombosis medication that has been in use for over 55 years. Its safety profile is well-established; as such, fast-track development of dipyridamole eye drops as a repurposed drug is feasible.

Moshe Rogosnitzky commented on this finding, "Pterygium and dry eye are debilitating disorders for which new safe solutions are urgently needed, and I believe dipyridamole has the potential to provide relief to sufferers of these intractable conditions.

Rogosnitzky, who specializes in finding new uses for old drugs, continued, "This is yet another example of the advantages of drug repurposing. Whereas bringing a new drug to market can take up to 17 years or more, finding a new use for an old drug with an excellent safety profile can lead to approval and availability in as little as two years."
-end-
The findings of this report and photos of the treated eye are published in Case Reports in Ophthalmology (2014; 5:pp. 98-103) on March 25, 2014.

About MedInsight® Research Institute

MedInsight® Research Institute is committed to bringing relief to those who suffer from cancer or chronic medical conditions by making doctors aware of commercially unsponsored medications, off-label uses for approved medicines, long-lost therapies and specialized tests that enable treatment to be tailored to the individual. As a U.S.-based 501(c)(3) non-profit organization, MedInsight works to bridge the widening gap between medical research and medical practice. http://www.medinsight.org

MedInsight Research Institute

Related Vision Articles:

Dressmakers found to have needle-sharp 3-D vision
Haute couture can be credited for enhancing more than catwalks and red carpets.
Vision keeps maturing until mid-life
The visual cortex, the human brain's vision-processing centre that was previously thought to mature and stabilize in the first few years of life, actually continues to develop until sometime in the late 30s or early 40s, a McMaster neuroscientist and her colleagues have found.
An innovative model for the study of vision
New approaches to the study of vision both from the neurobiological perspective and with a view to the technological development of artificial vision systems.
Everyone has different 'bad spots' in their vision
The ability to distinguish objects in peripheral vision varies significantly between individuals, finds new research from UCL, Paris Descartes University and Dartmouth College, USA.
New catalysts mimic human vision
Light sensitive molecules trigger vision inside our retinas. This phenomenon inspired ICIQ researchers to create a new family of eco-friendly catalysts activated by purple LEDs for unprecedented transformations.
A close look at sharp vision
Found only in the retinas of humans and other primates, the fovea is responsible for visual experiences that are rich in colorful, spatial detail.
Vision problems after concussion -- special issue of Optometry and Vision Science presents new research
Vision problems are a common and sometimes lasting consequence of head injuries -- from children and teens with sports-related concussions to military personnel with combat-related traumatic brain injury (TBI).
Survey: Vision health a priority
Most respondents across all ethnic and racial groups surveyed described loss of eyesight as the worst ailment that could happen to them when ranked against other conditions including loss of limb, memory, hearing, or speech, and indicated high support for ongoing research for vision and eye health, according to a study published online by JAMA Ophthalmology.
Portable artificial vision device may be an effective aid for patients with low vision
In a small study that included 12 legally blind participants, use of a portable artificial vision device improved the patient's ability to perform tasks simulating those of daily living, such as reading a message on an electronic device, a newspaper article or a menu, according to a study published online by JAMA Ophthalmology.
A new system for color vision
The swirling skies of Vincent Van Gogh's Starry Night illustrate a mystery that has eluded biologists for more than a century -- why do we perceive the color blue in the dimly lit night sky?

Related Vision Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".